awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33956478-E57DB10A-36EC-45D2-A650-B88D9E4BEF40
Q33956478-E57DB10A-36EC-45D2-A650-B88D9E4BEF40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956478-E57DB10A-36EC-45D2-A650-B88D9E4BEF40
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
P2860
Q33956478-E57DB10A-36EC-45D2-A650-B88D9E4BEF40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956478-E57DB10A-36EC-45D2-A650-B88D9E4BEF40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d377a88790b0da6ab4985962c3bc419c1cb7a47
P2860
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.